M&A Deal Summary |
|
---|---|
Date | 2014-12-01 |
Target | Sistem-9 |
Sector | Marketing |
Buyer(s) | NBK Capital Partners |
Deal Type | Buyout (LBO, MBO, MBI) |
Advisor(s) | Cukur & Yilmaz Law Firm (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 2005 |
PE ASSETS | 720M USD |
Size | Middle-Market |
Type | Sector Agnostic |
NBK Capital Partners is a private equity firm that makes investments in middle-market companies headquartered in the GCC, Turkey, the Levant and North Africa with high growth potential and significant opportunities for value creation. The Firm looks to invest between $10 to $60 million for companies with EBITDA typically ranging between $3 to $25 million. Sectors of interest include education, energy services and equipment, consumer products/services, and food. NBK Capital Partners was formed in 2005 and is based in Dubai, United Arab Emirates.
DEAL STATS | # |
---|---|
Overall | 18 of 25 |
Sector (Marketing) | 1 of 1 |
Type (Buyout (LBO, MBO, MBI)) | 6 of 8 |
Country (Turkey) | 8 of 9 |
Year (2014) | 3 of 3 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-07-01 |
Al Faysal Bakery
Kuwait City, Kuwait Al Faysal Bakery & Sweets Co. W.L.L. produces, distributes and exports packaged croissants, pastries, mini-pizzas and rusks to supermarkets, schools and convenience stores across Kuwait. Al Faysal Bakery & Sweets was founded in 1991 and is based in Kuwait City, Kuwait. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2015-03-09 |
Dem Pharmaceutical
Turkey Dem is a importer and marketer of niche drugs including blood products, hospital antibiotics, hematology and oncology drugs that are typically used to treat life threatening conditions based in Turkey. |
Sell | - |